Japanese researchers have come up with viable treatment plans for type 1 diabetes. A new study encourages transplanting patients' neural stem cells to the pancreas. Canadian pharmacies encourage cell transplantation processes, as they have long been considered optimum treatment for the disease. The study was published in the Journal EMBO Molecular Medicine and has generated some interest among experts.
The process used up until now involved using pancreatic tissue donated by healthy individuals and transferring it to people suffering from type 1 diabetes. The process is not viable as healthy tissue is in shortage. Also, recipients often do not accept pancreatic tissue from donors. With the number of cases increasing year by year, early detection appear to be a better option along with the new process.
Neural stem cells obtained from a patient is the ideal solution to overcome donor and cell rejection problems. Cells are obtained from the patient's own brain. The question of rejection does not arise, as they are transferred to the pancreas and converted into beta cells capable of producing insulin. The process was initiated by researchers from the AIS the Institute in Tsukuba, Japan.
No comments:
Post a Comment